Novel Technology Commercialization

Blazing a trail isn’t easy, but that’s not why you’re doing it. Navigating strategy for novel technologies and creating new, uncharted markets requires creativity, innovation, and experience. We’re here to help.

Our Experts

Stephane Budel

Miguel Edwards

Andrew Aijian

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Pharma & Biotech

Cell and Gene Therapy Service Market Opportunity Assessment

A startup wanted to understand how customers could use its cutting-edge technology and which applications to target for further development

View

Voice-of-Customer Research

Financial Services

High-Level Commercial Due Diligence in Digital Pathology

An early-stage venture firm requested a high-level commercial due diligence of a potential investment

View

Due Diligence

Pharma & Biotech

Biopharma Genomic Testing Market Research

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx

View

Voice-of-Customer Research

Research Tools

Synthetic Oligonucleotides Market Sizing

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

View

No items found.

Pharma & Biotech

Internal Lab Buildout Strategy

A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology

View

Voice-of-Customer Research

Due Diligence

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch